Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (6): 558-562.doi: 10.3969/j.issn.1000-6621.2020.06.005
• Original Articles • Previous Articles Next Articles
ZHANG Pei-ze, FU Liang, TAN Jie, WANG Yu-xiang, CHEN Tao, DENG Guo-fang()
Received:
2020-04-28
Online:
2020-06-10
Published:
2020-06-11
Contact:
DENG Guo-fang
E-mail:jxxk1035@yeah.net
ZHANG Pei-ze, FU Liang, TAN Jie, WANG Yu-xiang, CHEN Tao, DENG Guo-fang. CT imaging characteristics of cured multidrug-resistant pulmonary tuberculosis[J]. Chinese Journal of Antituberculosis, 2020, 42(6): 558-562. doi: 10.3969/j.issn.1000-6621.2020.06.005
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.06.005
CT征象 | CT检查时间点[例(率,%)] | χ2值 | P值 | ||
---|---|---|---|---|---|
停药时 | 随访12个月 | 随访24个月 | |||
活动性征象 | 24(57.1) | 18(42.9) | 13(31.0) | 5.872 | 0.053 |
磨玻璃状影 | 18(42.9) | 12(28.6) | 7(16.7) | 6.964 | 0.031 |
边界模糊结节状影 | 21(50.0) | 18(42.9) | 13(31.0) | 3.209 | 0.201 |
实变影 | 22(52.4) | 18(42.9) | 6(14.3) | 14.243 | 0.001 |
树芽征 | 5(11.9) | 5(11.9) | 4(9.5) | 0.161 | 0.923 |
空洞 | 13(31.0) | 13(31.0) | 12(28.6) | 0.075 | 0.963 |
稳定性征象 | 29(69.0) | 34(81.0) | 35(83.3) | 2.847 | 0.241 |
致密结节状病灶 | 22(52.4) | 26(61.9) | 29(69.0) | 2.471 | 0.291 |
支气管壁增厚 | 12(28.6) | 13(31.0) | 14(33.3) | 0.223 | 0.895 |
纤维条索状病灶 | 14(33.3) | 16(38.1) | 17(40.5) | 0.475 | 0.789 |
钙化 | 27(64.3) | 29(69.0) | 29(69.0) | 0.289 | 0.865 |
肺气肿 | 7(16.7) | 9(21.4) | 9(21.4) | 0.399 | 0.819 |
胸膜/纵隔淋巴结钙化 | 6(14.3) | 6(14.3) | 6(14.3) | 0.000 | 1.000 |
不确定性征象 | 17(40.5) | 17(40.5) | 17(40.5) | 0.000 | 1.000 |
薄壁空洞和囊腔 | 6(14.3) | 6(14.3) | 6(14.3) | 0.000 | 1.000 |
未钙化的斑块状病灶 | 14(33.3) | 12(28.6) | 12(28.6) | 0.301 | 0.860 |
毁损肺 | 11(26.2) | 11(26.2) | 11(26.2) | 0.000 | 1.000 |
肺不张 | 6(14.3) | 6(14.3) | 6(14.3) | 0.000 | 1.000 |
胸膜增厚 | 7(16.7) | 7(16.7) | 7(16.7) | 0.000 | 1.000 |
CT征象 随访时间点 | 组别[例(率,%)] | χ2值 | P值 | |
---|---|---|---|---|
初治(18例) | 复治(24例) | |||
活动性征象 | ||||
停药时 | 6(33.3) | 18(75.0) | 7.292 | 0.007 |
停药12个月时 | 5(27.8) | 13(54.2) | 2.925 | 0.087 |
停药24个月时 | 4(22.2) | 9(37.5) | 1.123 | 0.289 |
稳定性征象 | ||||
停药时 | 9(50.0) | 20(83.3) | 5.347 | 0.021 |
停药12个月时 | 15(83.3) | 19(79.2) | 0.116 | 1.000 |
停药24个月时 | 16(88.9) | 19(79.2) | 0.700 | 0.679 |
不确定性征象 | ||||
停药时 | 3(16.7) | 14(58.3) | 7.412 | 0.006 |
停药12个月时 | 3(16.7) | 14(58.3) | 7.412 | 0.006 |
停药24个月时 | 3(16.7) | 14(58.3) | 7.412 | 0.006 |
[1] | World Health Organization. Global tuberculosis report 2019. Geneva: World Health Organization, 2019. |
[2] |
GBD Tuberculosis Collaborators . Global, regional, and national burden of tuberculosis, 1990—2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study. Lancet Infect Dis, 2018,18(12):1329-1349.
doi: 10.1016/S1473-3099(18)30625-X URL |
[3] | Dheda K, Gumbo T, Maartens G , et al. The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respir Med, 2017. pii: S2213-2600(17) 30079-6. |
[4] |
Bastos ML, Lan Z, Menzies D . An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis. Eur Respir J, 2017, 49(3). pii: 1600803.
doi: 10.1183/13993003.00803-2016 URL |
[5] | 周婕, 党丽云, 沈聪 , 等. 耐多药肺结核患者胸部影像学特征分析. 实用放射学杂志, 2018,34(9):1348-1350, 1385. |
[6] | 中国防痨协会. 耐药结核病化学治疗指南(2019年简版). 中国防痨杂志, 2019,41(10):1025-1073. |
[7] | 国家感染性疾病临床医学研究中心, 深圳市第三人民医院, 《中国防痨杂志》编辑委员会. 肺结核活动性判断规范及临床应用专家共识. 中国防痨杂志, 2020,42(4):301-307. |
[8] |
Ahmad Khan F, Pande T, Tessema B , et al. Computer-aided reading of tuberculosis chest radiography: moving the research agenda forward to inform policy. Eur Respir J, 2017, 50(1). pii: 1700953.
doi: 10.1183/13993003.00953-2017 URL |
[9] | 刘奉凤, 严晓峰, 吕圣秀 , 等. 低剂量胸部CT扫描在评估肺结核治疗效果中的价值. 中国社区医师, 2018,34(29):122-123, 125. |
[10] | 赵鸿鹏, 路希维 . 影像学检查在肺结核诊治中的应用现状与展望. 结核病与肺部健康杂志, 2019,8(1):5-8. |
[11] |
Kim W, Lee KS, Kim HS , et al. CT and microbiologic follow-up in primary multidrug-resistant pulmonary tuberculosis. Acta Radiol, 2016,57(2):197-204.
doi: 10.1177/0284185115575196 URL |
[12] |
Bestrashniy JRBM, Nguyen VN, Nguyen TL , et al. Recurrence of tuberculosis among patients following treatment completion in eight provinces of Vietnam: A nested case-control study. Int J Infect Dis, 2018,74:31-37.
doi: 10.1016/j.ijid.2018.06.013 URL |
[13] |
Meghji J, Simpson H, Squire SB , et al. A systematic review of the prevalence and pattern of imaging defined post-TB lung disease. PLoS One, 2016,11(8):e0161176.
doi: 10.1371/journal.pone.0161176 URL |
[14] |
Godoy MD, Mello FC, Lopes AJ , et al. The functional assessment of patients with pulmonary multidrug-resistant tuberculosis. Respir Care, 2012,57(11):1949-1954.
doi: 10.4187/respcare.01532 URL |
[15] | 伍建林, 路希伟, 张竞文 , 等. 60例活动性肺结核治疗转归与随访的多层螺旋CT应用评价. 中国临床医学影像杂志, 2009,20(2):84-88. |
[16] |
Li D, He W, Chen B , et al. Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings. PLoS One, 2017,12(6):e0176354.
doi: 10.1371/journal.pone.0176354 URL |
[17] | Te Riele JB, Buser V, Calligaro G , et al. Relationship between chest radiographic characteristics, sputum bacterial load, and treatment outcomes in patients with extensively drug-resistant tuberculosis. Int J Infect Dis, 2019,79:65-71. |
[18] | 杨宏志, 廖昆仑, 张晖 . 难治性肺结核的CT影像特点及治疗效果观察. 影像研究与医学应用, 2018,2(23):231-233. |
[19] | 苏瑾文, 程小星 . 肺结核的保护性免疫和免疫病理机制进展. 中国热带医学, 2015,15(5):635-639. |
[1] | Tuberculosis Control Branch of Chinese Antituberculosis Association, The Youth Branch of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Evidence-based guidelines for application of digital adherence technology in tuberculosis medication management in China [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 385-397. |
[2] | Li Jinhao, Hu Dongmei, Xu Caihong. Investigation on the willingness of tuberculosis health-care workers to implement tuberculosis preventive treatment and analysis of influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 398-407. |
[3] | Li Yuhong, Mei Jinzhou, Su Wei, Ruan Yunzhou, Liu Yushu, Zhao Yanlin, Liu Xiaoqiu. Analysis of the treatment outcomes and influencing factors of rifampicin-resistant pulmonary tuberculosis patients aged 65 and above in China from 2015 to 2021 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 408-415. |
[4] | Jiang Xue, Bai Yunlong, Ma Jianjun, An Yuan, Yang Fan, Zhao Qinglong. Status and influencing factors of diagnosis and treatment delay of rifampicin resistant pulmonary tuberculosis patients, Jilin Province, 2020—2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 416-424. |
[5] | Wu Xuan, Zhang Yanqiu, Xu Jiying, Meng Dan, Sun Dingyong. Analysis of factors influencing the treatment outcomes of patients with pulmonary tuberculosis and diabetes mellitus in Henan Province (2019—2023) [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 425-431. |
[6] | An Yuan, Bai Yunlong, Zhao Qinglong, Ma Jianjun, Jiang Xue, Pan Yan, Gao Ying, Gao Zhihui. Analysis of treatment outcomes and influencing factors of patients with pulmonary tuberculosis complicated with diabetes mellitus in Jilin Province,2018—2022 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 432-438. |
[7] | Feng Wei, Zheng Hailun, Meng Weili, Luo Ping. Analysis of under-reporting before arrival of pulmonary tuberculosis patients registered and managed by Tuberculosis Prevention and Control Institutions in Xicheng District, Beijing from 2018 to 2023 [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 439-443. |
[8] | Hu Yifan, Du Boping, Wu Yadong, Zhu Chuanzhi, Zhang Lanyue, Jia Hongyan, Sun Qi, Pan Liping, Zhang Zongde, Li Zihui. Experimental study on the role of Mce4C in the uptake and utilization of cholesterol by Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 444-453. |
[9] | Sheng Jie, Hong Kaifeng, Mierzhati Aisha, Tang Wei, Dilixiati Abulizi. Study on the mechanism of IL-22 and p38 MAPK signaling pathways in inhibiting bone destruction in bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 454-459. |
[10] | Wang Yingchao, Liu Weiyi, Ji Xiuxiu, Shang Xuetian, Jia Hongyan, Zhang Lanyue, Sun Qi, Du Boping, Zhu Chuanzhi, Pan Liping, Zhang Zongde. Profile analysis of circRNA expression and identification of diagnostic markers in peripheral blood mononuclear cells of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 460-470. |
[11] | Zhu Mingzhi, Shao Yanqin, Fan Dapeng, Liu Libin, Mei Bin, Dai Lingshan, Cai Long. Diagnostic value of urine lipoarabinomannan antigen detection in extrapulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 471-476. |
[12] | Hao Mingxiao, Mi Jie, Xu Zongyi. Effectiveness of a continuity of care model in patients with tuberculous meningitis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 477-481. |
[13] | Shang Xiyu, Zhang Huifang, Cao Yuqing, Xiong Yibai, Ji Xinyu, Tian Yaxin, Li Jiajia, Wang Ni, Ma Yan. Bibliometric analysis of global research status and hotspots in the basic research of Traditional Chinese Medicine for tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 482-497. |
[14] | Qin Lili, Yang Chengqing, Mai Hongzhen, Xu Qifeng, Xue Xinying, Lu Xiwei. Advances in the clinical diagnosis and treatment of post-tuberculosis chronic pulmonary aspergillosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 498-504. |
[15] | Luo Li, Luo Linzi, Yin Quhua, Zhou Lei, Lu Zhibin, Ding Yan, Xiao Yangbao. Progress in bronchoscopic diagnosis and treatment of lymph node fistula tracheobronchial tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(4): 505-512. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||